Agonism of S1PR1 has recently been shown to modulate IFN alpha (IFNα) signaling, a critical inflammatory driver in autoimmune diseases including type 1 diabetes and SLE. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.